169 related articles for article (PubMed ID: 37958994)
21. Auraptene Induces Apoptosis via Myeloid Cell Leukemia 1-Mediated Activation of Caspases in PC3 and DU145 Prostate Cancer Cells.
Lee JC; Shin EA; Kim B; Kim BI; Chitsazian-Yazdi M; Iranshahi M; Kim SH
Phytother Res; 2017 Jun; 31(6):891-898. PubMed ID: 28383142
[TBL] [Abstract][Full Text] [Related]
22. 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.
Shin DJ; Kim JE; Lim TG; Jeong EH; Park G; Kang NJ; Park JS; Yeom MH; Oh DK; Bode AM; Dong Z; Lee HJ; Lee KW
J Cell Biochem; 2014 Oct; 115(10):1702-11. PubMed ID: 24821673
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling.
Nadile M; Sze NSK; Fajardo VA; Tsiani E
Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732504
[TBL] [Abstract][Full Text] [Related]
24. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Zeng J; Liu W; Fan YZ; He DL; Li L
Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
[No Abstract] [Full Text] [Related]
25. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
Rattan R; Giri S; Hartmann LC; Shridhar V
J Cell Mol Med; 2011 Jan; 15(1):166-78. PubMed ID: 19874425
[TBL] [Abstract][Full Text] [Related]
26. Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.
Biernacka KM; Persad RA; Bahl A; Gillatt D; Holly JM; Perks CM
Endocr Relat Cancer; 2017 Jan; 24(1):17-30. PubMed ID: 27754854
[TBL] [Abstract][Full Text] [Related]
27. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.
Ha S; Iqbal NJ; Mita P; Ruoff R; Gerald WL; Lepor H; Taneja SS; Lee P; Melamed J; Garabedian MJ; Logan SK
Oncogene; 2013 Aug; 32(34):3992-4000. PubMed ID: 22986532
[TBL] [Abstract][Full Text] [Related]
29. Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.
Li W; Hua B; Saud SM; Lin H; Hou W; Matter MS; Jia L; Colburn NH; Young MR
Mol Carcinog; 2015 Oct; 54(10):1096-109. PubMed ID: 24838344
[TBL] [Abstract][Full Text] [Related]
30. eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.
Thors B; Halldórsson H; Thorgeirsson G
Biochim Biophys Acta; 2011 Feb; 1813(2):322-31. PubMed ID: 21145922
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of LKB1 by PDK1 Inhibits Cell Proliferation and Organ Growth by Decreased Activation of AMPK.
Borkowsky S; Gass M; Alavizargar A; Hanewinkel J; Hallstein I; Nedvetsky P; Heuer A; Krahn MP
Cells; 2023 Mar; 12(5):. PubMed ID: 36899949
[TBL] [Abstract][Full Text] [Related]
32. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
33. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
Ben Jemaa A; Sallami S; Céraline J; Oueslati R
Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
[TBL] [Abstract][Full Text] [Related]
34. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
Xu Y; Chen SY; Ross KN; Balk SP
Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
Sarwar M; Sandberg S; Abrahamsson PA; Persson JL
Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945
[TBL] [Abstract][Full Text] [Related]
36. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.
Tennakoon JB; Shi Y; Han JJ; Tsouko E; White MA; Burns AR; Zhang A; Xia X; Ilkayeva OR; Xin L; Ittmann MM; Rick FG; Schally AV; Frigo DE
Oncogene; 2014 Nov; 33(45):5251-61. PubMed ID: 24186207
[TBL] [Abstract][Full Text] [Related]
37. A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest.
Majd S; Power JHT; Chataway TK; Grantham HJM
BMC Cell Biol; 2018 Jun; 19(1):7. PubMed ID: 29921218
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of serine 399 in LKB1 protein short form by protein kinase Cζ is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation.
Zhu H; Moriasi CM; Zhang M; Zhao Y; Zou MH
J Biol Chem; 2013 Jun; 288(23):16495-16505. PubMed ID: 23612973
[TBL] [Abstract][Full Text] [Related]
39. Metastasis suppression by adiponectin: LKB1 rises up to the challenge.
Saxena NK; Sharma D
Cell Adh Migr; 2010; 4(3):358-62. PubMed ID: 20418665
[TBL] [Abstract][Full Text] [Related]
40. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
